Cell delivery to the central nervous system

被引:62
作者
Shoichet, MS
Winn, SR
机构
[1] Univ Toronto, Inst Biomat & Biomed Engn, Dept Chem, Dept Chem Engn & Appl Chem, Toronto, ON M55 3E5, Canada
[2] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA
关键词
D O I
10.1016/S0169-409X(00)00055-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A dysfunctional central nervous system (CNS) resulting from neurological disorders and diseases impacts all of humanity. The outcome presents a staggering health care issue with a tremendous potential for developing interventive therapies. The delivery of therapeutic molecules to the CNS has been hampered by the presence of the blood-brain barrier (BBB). To circumvent this barrier, putative therapeutic molecules have been delivered to the CNS by such methods as pumps/osmotic pumps, osmotic opening of the BBB, sustained polymer release systems and cell delivery via site-specific transplantation of cells. This review presents an overview of some of the CNS delivery technologies with special emphasis on transplantation of cells with and without the use of polymer encapsulation technology. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:81 / 102
页数:22
相关论文
共 148 条
  • [1] TRANSPLANTATION OF NEURAL TISSUE IN POLYMER CAPSULES
    AEBISCHER, P
    WINN, SR
    GALLETTI, PM
    [J]. BRAIN RESEARCH, 1988, 448 (02) : 364 - 368
  • [2] Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients
    Aebischer, P
    Schluep, M
    Deglon, N
    Joseph, JM
    Hirt, L
    Heyd, B
    Goddard, M
    Hammang, JP
    Zurn, AD
    Kato, AC
    Regli, F
    Baetge, EE
    [J]. NATURE MEDICINE, 1996, 2 (06) : 696 - 699
  • [3] TRANSPLANTATION OF MICROENCAPSULATED BOVINE CHROMAFFIN CELLS REDUCES LESION-INDUCED ROTATIONAL ASYMMETRY IN RATS
    AEBISCHER, P
    TRESCO, PA
    SAGEN, J
    WINN, SR
    [J]. BRAIN RESEARCH, 1991, 560 (1-2) : 43 - 49
  • [4] TRANSPLANTATION IN HUMANS OF ENCAPSULATED XENOGENEIC CELLS WITHOUT IMMUNOSUPPRESSION - A PRELIMINARY-REPORT
    AEBISCHER, P
    BUCHSER, E
    JOSEPH, JM
    FAVRE, J
    DETRIBOLET, N
    LYSAGHT, M
    RUDNICK, S
    GODDARD, M
    [J]. TRANSPLANTATION, 1994, 58 (11) : 1275 - 1277
  • [5] AEBISCHER P, 1994, EXP NEUROL, V126, P1
  • [6] DIFFERENTIAL DISTRIBUTION OF EXOGENOUS BDNF, NGF, AND NT-3 IN THE BRAIN CORRESPONDS TO THE RELATIVE ABUNDANCE AND DISTRIBUTION OF HIGH-AFFINITY AND LOW-AFFINITY NEUROTROPHIN RECEPTORS
    ANDERSON, KD
    ALDERSON, RF
    ALTAR, CA
    DISTEFANO, PS
    CORCORAN, TL
    LINDSAY, RM
    WIEGAND, SJ
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 357 (02) : 296 - 317
  • [7] Intrathecal morphine pump as a treatment option in chronic pain of nonmalignant origin
    Angel, IF
    Gould, HJ
    Carey, ME
    [J]. SURGICAL NEUROLOGY, 1998, 49 (01): : 92 - 98
  • [8] EFFECTS OF TRANSFERRIN RECEPTOR ANTIBODY-NGF CONJUGATE ON YOUNG AND AGED SEPTAL TRANSPLANTS IN OCULO
    BACKMAN, C
    BIDDLE, PT
    EBENDAL, T
    FRIDEN, PM
    GERHARDT, GA
    HENRY, MA
    MACKERLOVA, L
    SODERSTROM, S
    STROMBERG, I
    WALUS, L
    HOFFER, BJ
    GRANHOLM, AC
    [J]. EXPERIMENTAL NEUROLOGY, 1995, 132 (01) : 1 - 15
  • [9] BIOCHEMICAL AND BEHAVIORAL CORRECTION OF MPTP PARKINSON-LIKE SYNDROME BY FETAL CELL TRANSPLANTATION
    BAKAY, RAE
    BARROW, DL
    FIANDACA, MS
    IUVONE, PM
    SCHIFF, A
    COLLINS, DC
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 495 : 623 - 640
  • [10] BANKS W, 1990, NEUROSURGERY, V259, pE1